Clinical Trial

A Study to Evaluate the Efficacy and Safety in Subjects With Advanced Breast Cancer Treated With SYHX2011

Name: A Study to Evaluate the Efficacy and Safety in Subjects With Advanced Breast Cancer Treated With SYHX2011 — clinical trial record (NCT06354114)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Record status

This record was last updated April 9, 2024 (before its estimated October 31, 2024 completion). Its status may not reflect the trial's current state.

Summary

The main purpose of this study is to evaluate the efficacy and safety in subjects with advanced breast cancer treated with SYHX2011

Trial Details

NCT Number	NCT06354114
Lead Sponsor	CSPC Ouyi Pharmaceutical Co., Ltd.
Conditions	Advanced Breast Cancer
Enrollment	80 participants
Start Date	2024-04
Primary Completion	2024-10-31 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2024-04-09